IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Prosight Management, LP

Q4 2018 Holdings

Filed 2019-02-14 | 35 holdings | $16.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$8.8M103,00052.9%
Axogen Inc(AXGN)COM05463X106$4.3M209,08825.8%
Aldeyra Therapeutics Inc(ALDX)COM01438T106$3.4M404,46320.3%
Hanger IncCOM NEW41043F208$22.5K1,189,3990.1%
Reata Pharmaceuticals Inc(RETAEUR)CL A75615P103$14.2K253,0000.1%
Cigna Corp New(CI)COM125523100$13.9K73,3000.1%
Wellcare Health Plans IncCOM94946T106$11.8K50,0000.1%
Arena Pharmaceuticals Inc(ARNAEUR)COM NEW040047607$10.8K277,6500.1%
Zimmer Biomet Hldgs Inc(ZBH)COM98956P102$10.7K103,3800.1%
Iovance Biotherapeutics Inc(IOVA)COM462260100$9.4K1,062,5000.1%
Allergan PLCSHSG0177J108$8.2K61,4000.0%
Albireo Pharma Inc(BDQM)COM01345P106$6.6K270,1460.0%
Assembly Biosciences IncCOM045396108$6.2K275,9410.0%
Galapagos NV(GLPG)SPON ADR36315X101$5.8K62,8500.0%
Intec Pharma LTD JerusalemSHSM53644106$5.1K676,1040.0%
Teligent Inc NewCOM87960W104$4.9K3,547,6070.0%
Asgn Inc(ASGN)COM00191U102$4.8K87,7000.0%
Viking Therapeutics Inc(VKTX)COM92686J106$4.8K624,0000.0%
Providence SVC CorpCOM743815102$4.7K78,2980.0%
Kura Oncology Inc(KURA)COM50127T109$4.4K316,5810.0%
Strongbridge Biopharma PLCSHS USDG85347105$4.2K937,9000.0%
Catalyst Biosciences IncCOM NEW14888D208$3.7K466,9000.0%
Sierra Oncology IncCOM82640U107$3.4K2,553,9430.0%
Centene Corp del(CNC)COM15135B101$2.9K25,0000.0%
Macrogenics Inc(MGNX)COM556099109$2.5K194,1290.0%
Evolus Inc(EOLS)COM30052C107$2.3K195,9110.0%
Millendo Therapeutics IncCOM60040X103$2.0K256,7390.0%
Ligand Pharmaceuticals Inc(LGND)COM NEW53220K504$1.7K12,6000.0%
Triple-S Mgmt Corp(GTS)CL B896749108$1.1K65,5150.0%
Clovis Oncology Inc(CLVSEUR)COM189464100$1.1K60,1000.0%
Cerecor IncCOM15671L109$994307,7330.0%
Pieris Pharmaceuticals IncCOM720795103$885332,8460.0%
Optinose IncCOM68404V100$870140,3140.0%
Cidara Therapeutics IncCOM171757107$578245,7640.0%
Aquinox Pharmaceuticals IncCOM03842B101$17380,2890.0%